Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (KR1020170090359) NOVEL HUMAN GUT-DERIVED LACTIC ACID BACTERIA HAVING IMMUNE REGULATORY FUNCTION AND USAGE THEREOF

Office : Republic of Korea
Application Number: 1020170010824 Application Date: 24.01.2017
Publication Number: 1020170090359 Publication Date: 07.08.2017
Grant Number: 1019373640000 Grant Date: 11.01.2019
Publication Kind : B1
IPC:
C12N 1/20
A23L 33/135
A61K 35/744
A61K 35/745
A61K 35/747
C12R 1/01
C12R 1/225
C12R 1/23
C12R 1/25
C12R 1/46
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1
Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
20
Bacteria; Culture media therefor
[IPC code unknown for A23L 33/135][IPC code unknown for A61K 35/744][IPC code unknown for A61K 35/745][IPC code unknown for A61K 35/747]
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
225
Lactobacillus
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
225
Lactobacillus
23
Lactobacillus acidophilus
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
225
Lactobacillus
25
Lactobacillus plantarum
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
46
Streptococcus
Applicants: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITYUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
경희대학교 산학협력단
Inventors: KIM, DONG HYUNKIM, DONG HYUN
HAN, MYUNG JOOHAN, MYUNG JOO
김동현
한명주
Agents: 안소영
Priority Data: 1020160010761 28.01.2016 KR
Title: (EN) NOVEL HUMAN GUT-DERIVED LACTIC ACID BACTERIA HAVING IMMUNE REGULATORY FUNCTION AND USAGE THEREOF
(KO) 면역조절 작용을 가는 사람 소화관 유래 신규 유산균 및 이의 용도
Abstract: front page image
(EN) According to the present invention, specific Lactobacillus sp. strains, Bifidobacterium sp. strains, Streptococcus sp. strains, or Collinsella sp. strains are isolated from human feces, are highly safe, and have various physiological activities such as immune regulatory effects, immune enhancing effects, anti-allergic effects, anti-inflammatory effects, colitis alleviation effects, arthritis alleviating effects, anti-obesity effects, anti-stress effects, anti-anxiety effects, anti-depression effects, or anti-schizophrenia effects. The specific Lactobacillus sp. strain, the specific Bifidobacterium sp. strain, the specific Streptococcus sp. strain or the specific Collinsella sp. strain according to the present invention can be used as a substance for immune regulation, immune enhancement, inflammatory response inhibition, and stress alleviation or as a functional food and pharmaceutical substance useful for preventing, alleviating, and treating allergic diseases, inflammatory diseases, colitis, arthritis, obesity, anxiety disorders, depression, schizophrenia or the like. COPYRIGHT KIPO 2017
(KO) 본 발명에 따른 특정 락토바실러스속 균주, 특정 비피도박테리움속 균주, 특정 스트렙토코커스속 균주 또는 특정 콜린셀라속 균주는 사람의 분변에서 분리되어 안전성이 높고 면역조절 효능, 면역증강 효능, 항알러지 효능, 항염증 효능, 대장염 개선 효능, 관절염 개선 효능, 항비만 효능, 항스트레스 효능, 항불안 효능, 항우울 효능 또는 항정신분열 효능과 같은 다양한 생리활성을 갖는다. 본 발명에 따른 특정 락토바실러스속 균주, 특정 비피도박테리움속 균주, 특정 스트렙토코커스속 균주 또는 특정 콜린셀라속 균주는 면역조절, 면역증강, 염증반응 억제, 스트레스 완화를 위한 소재로 사용될 수도 있고, 알러지 질환, 염증 질환, 대장염, 관절염, 비만, 불안 장애, 우울증 또는 정신분열증 등을 예방, 개선 또는 치료하는데에 유용한 기능성 식의약 소재로도 사용될 수 있다.